Showing results (161-170 of 423) with videos related to
Sort By:
Pageof 43
Journal of Chemotherapy (Florence, Italy)|April 18, 2000
Ceftazidime for outpatient parenteral antibiotic therapy (OPAT) of chronic suppurative otitis media due to Pseudomonas aeruginosaS Esposito, S Noviello, F Ianniello, et al.Le Infezioni in Medicina|April 26, 2003
[Treatment of streptococcal tonsillo-pharyngitis in paediatric patients: short-course therapy with cefaclor]S. Esposito, S. Noviello, F. Ianniello, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2001
Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infectionsN Principi, S Esposito, F Blasi, et al.Bollettino Della Societa Italiana Di Biologia Sperimentale|November 30, 1983
[In vitro activity of beta-lactam antibiotics and their sensitivity to beta-lactamase]S Esposito, D Galante, C Pennucci, et al.Microbiologica|July 1, 1985
Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivativesS Esposito, D Galante, C Pennucci, et al.Chemotherapy|October 2, 1998
Erythromycin resistance in group A beta hemolytic streptococcusS Esposito, S Noviello, F Ianniello, et al.International Journal of Antimicrobial Agents|November 3, 2001
Short-course therapy with cefaclor for treatment of streptococcal pharyngotonsillitisS Esposito, S Noviello, F Ianniello, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 21, 2001
Use of antimicrobial agents for community-acquired lower respiratory tract infections in hospitalised childrenS Esposito, F Blasi, L Allegra, et al.Le Infezioni in Medicina|April 23, 2003
[In vitro susceptibility of different erythromycin-resistant phenotypes of Streptococcus pyogenes to moxifloxacin and other fluoroquinolones]S. Novielllo, F. Ianniello, S. Esposito, et al.Journal of Chemotherapy (Florence, Italy)|April 18, 2000
New insight into the clinical pharmacokinetics of cefaclor: tissue penetrationT Mazzei, A Novelli, S Esposito, et al.Pageof 43